Cargando…

Favipiravir versus standard of care in patients with severe COVID-19 infections: A retrospective comparative study

OBJECTIVE: To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection. METHODS: This is a retrospective cohort of patients with COVID-19 pneumonia who were treated with favipiravir, versus comparison group that received the standard of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almoosa, Zainab, Saad, Mustafa, Qara, Samer, Mustafa, Mahmoud, Mansour, Ali, Alshab, Duaa, Alhashem, Jehad, ALKhawajah, Sajida, Alkhalifah, Saleh, ALmarzooq, Mokhtar, ALzain, Mohammed, Anshasi, Neda’a, Ahmed, Gasmelseed, Mutair, Abbas Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382493/ https://www.ncbi.nlm.nih.gov/pubmed/34464921 http://dx.doi.org/10.1016/j.jiph.2021.08.022

Ejemplares similares

Healthcare Provider Attitudes toward the Newly Developed COVID-19 Vaccine: Cross-Sectional Study
por: Ahmed, Gasmelseed, et al.
Publicado: (2021)

Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia
por: Mutair, Abbas Al, et al.
Publicado: (2022)

Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital
por: Eldaabossi, Safwat A.M., et al.
Publicado: (2021)

Voltammetric sensor based on bimetallic nanocomposite for determination of favipiravir as an antiviral drug
por: Mehmandoust, Mohammad, et al.
Publicado: (2021)

Invasive Candidiasis in Pediatric Patients at King Fahad Medical City in Riyadh, Saudi Arabia: A 5-year Retrospective Study
por: Almoosa, Zainab
Publicado: (2017)

Invasive Candidiasis in pediatric patients at King Fahad Medical City in Central Saudi Arabia: A 5-year retrospective study
por: Almoosa, Zainab, et al.
Publicado: (2017)

Favipiravir Experience in COVID-19 Patients at a Tertiary Center Intensive Care Unit
por: Sevinc, Sultan Acar, et al.
Publicado: (2022)

An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19
por: Karatas, Hacer, et al.
Publicado: (2022)

Knowledge of infection prevention and control among healthcare workers and factors influencing compliance: a systematic review
por: Alhumaid, Saad, et al.
Publicado: (2021)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comparison Between Physiological Scores SIPF, CURB-65, and APACHE II as Predictors of Prognosis and Mortality in Hospitalized Patients with COVID-19 Pneumonia: A Multicenter Study, Saudi Arabia
por: Eldaboosy, Safwat, et al.
Publicado: (2022)

Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
por: Alotaibi, Musim, et al.
Publicado: (2021)

A prospective study of the association between sickle cell disease and hepatobiliary effects in Bahrain
por: Abdulla, Maheeba A M, et al.
Publicado: (2017)

The mechanism of resistance to favipiravir in influenza
por: Goldhill, Daniel H., et al.
Publicado: (2018)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum
por: Eryavuz Onmaz, Duygu, et al.
Publicado: (2021)

Electrochemical Sensing of Favipiravir with an Innovative Water-Dispersible Molecularly Imprinted Polymer Based on the Bimetallic Metal-Organic Framework: Comparison of Morphological Effects
por: Erk, Nevin, et al.
Publicado: (2022)

Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma
por: Hailat, Mohammad, et al.
Publicado: (2021)

Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
por: Alhumaid, Saad, et al.
Publicado: (2020)

Favipiravir tautomerism: a theoretical insight
por: Antonov, Liudmil
Publicado: (2020)

Role of favipiravir in the treatment of COVID-19
por: Joshi, Shashank, et al.
Publicado: (2021)

Novel Polymorph of Favipiravir—An Antiviral Medication
por: Goloveshkin, Alexander S., et al.
Publicado: (2021)

SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Favipiravir: Drug fever: case report
Publicado: (2021)

Favipiravir—Tautomeric and Complexation Properties in Solution
por: Deneva, Vera, et al.
Publicado: (2022)

Contained Jejunal Perforation Secondary to Ingestion of Magnet Balls in a Nonfatal Drowning Child
por: Kattih, Osama, et al.
Publicado: (2022)

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Clustering of Covid-19 infections among healthcare workers: Experience from a tertiary care center in Saudi Arabia
por: Saad, Mustafa M., et al.
Publicado: (2022)

Estimated cost of treating hospitalized COVID-19 patients in Saudi Arabia
por: Al Mutair, Abbas, et al.
Publicado: (2022)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Examining the Clinical Prognosis of Critically Ill Patients with COVID-19 Admitted to Intensive Care Units: A Nationwide Saudi Study
por: Al Mutair, Abbas, et al.
Publicado: (2021)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Favipiravir for COVID-19 in a Patient on Hemodialysis
por: Hirai, Daisuke, et al.
Publicado: (2021)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Bengue, Michèle, et al.
Publicado: (2021)

Use of Favipiravir in Lactating Mother With COVID-19
por: Karabayır, Nalan, et al.
Publicado: (2021)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Future of antivirals in COVID-19: The case of favipiravir
por: Kow, Chia Siang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vl8e7j61ha45lpbnoovk9ipb8q